<li id="omoqo"></li>
  • <noscript id="omoqo"><kbd id="omoqo"></kbd></noscript>
  • <td id="omoqo"></td>
  • <option id="omoqo"><noscript id="omoqo"></noscript></option>
  • <noscript id="omoqo"><source id="omoqo"></source></noscript>
  • 發布時間:2019-08-08 23:27 原文鏈接: 親和層析凝膠指南

    GE Healthcare
    Benzamidine Sepharose&#8482; 6B is p-aminobenzamidine covalently
    attached to Sepharose 6B by the epoxy coupling method.
    p-Aminobenzamidine (PAB), is a synthetic inhibitor of trypsin-like
    serine protease. Trypsin and trypsin-like serine proteases bind to
    Benzamidine Sepharose 6B and can thus be used for purification and/
    or removal of these substances. Trypsin, bovine thrombin, urokinase,
    human enterokinase, acrosin, native plasminogen, kallikrein,
    prekallikrein, collagenase and clostripain are some of the serine
    proteases that have been purified on Benzamidine Sepharose 6B.
    For recombinant purification, Benzamidine Sepharose 6B can be used
    for removal of serine proteases such as thrombin and enterokinase
    after cleavage of purification tags.
    Sample TextSepharose and Drop Design are trademarks of GE Healthcare companies. GE, imagination at work and GE monogram are
    trademarks of General Electric Company.
    Triton is a trademark of Union Carbide Chemicals and Plastics Co.
    All goods and services are sold subject to the terms and conditions of sale of the company within GE Healthcare which
    supplies them. GE Healthcare reserves the right, subject to any regulatory and contractual approval, if required, to make
    changes in specifications and features shown herein, or discontinue the product described at any time without notice or
    obligation. Contact your local GE Healthcare representative for the most current information.
    &copy; 2006 General Electric Company – All rights reserved.
    GE Healthcare AB, a General Electric Company.
    GE Healthcare Europe GmbH
    Munzinger Strasse 5
    D-79111 Freiburg
    Germany
    GE Healthcare UK Ltd.
    Amersham Place
    Little Chalfont
    Buckinghamshire, HP7 9NA
    UK
    GE Healthcare Bio-Sciences Corp.
    800 Centennial Avenue
    P.O. Box 1327
    Piscataway, NJ 08855-1327
    USA
    GE Healthcare Bio-Sciences KK
    Sanken Bldg.
    3-25-1, Hyakunincho
    Shinjuku-ku, Tokyo 169-0073
    Japan
    www.gehealthcare.com/protein-purification
    www.gehealthcare.com
    GE Healthcare Bio-Sciences AB
    Bj&ouml;rkgatan 30
    751 84 Uppsala
    Sweden
    71-7096-00 AE 07/2006
    Elanders &Ouml;sterv&aring;la 2006 12345
    Elanders &Ouml;sterv&aring;la 2006 12345
    Elanders &Ouml;sterv&aring;la 2006
    Elanders &Ouml;sterv&aring;la 2006
    Elanders &Ouml;sterv&aring;la 2006 12345
    Elanders &Ouml;sterv&aring;la 2006 12345
    Elanders &Ouml;sterv&aring;la 2006
    Elanders &Ouml;sterv&aring;la 2006
    imagination at workTable 1. Medium characteristics.
    Ligand density: 7 μmole p-aminobenzamidine/ml
    drained media
    Available capacity*: 13 mg trypsin/ml drained media
    Bead structure: 6% agarose
    Bead size range: 45–165 μm
    Mean particle size: 90 μm
    Max linear flow rate**: 75 cm/h at 25°C, HR 16/10 column,
    5 cm bed height
    pH stability***
    Long term: 3–11
    Short term: 2–13
    Chemical stability: Stable to all commonly used aqueous
    buffers
    Physical stability: Negligible volume variation due to
    changes in pH or ionic strength
    * The binding capacity was determinded in 50 mM Tris-HCI,
    pH 8.0 containing 0.5 M NaCl.
    ** Linear flow rate =
    Volumetric flow rate (cm3/h)
    column cross-sectional area (cm2)
    *** The ranges given are estimates based on our knowledge and
    experience. Please note the following:
    pH stability, long term refers to the pH interval where the medium
    is stable over a long period of time without adverse effects on its
    subsequent chromatographic performance.
    pH stability, short term refers to the pH interval for regeneration
    and cleaning.Contents
    1. Preparing the medium 3
    2. Packing Sepharose 6B medium 4
    3. Using an adaptor 5
    4. Binding of protein 5
    5. Elution of protein 6
    6. Regeneration 6
    7. Cleaning 7
    8. Storage 7
    9. Ordering Information 7
    10. References 7
    1. Preparing the medium
    Benzamidine Sepharose 6B is supplied pre-swollen in 20%
    ethanol. Prepare a slurry by decanting the ethanol solution
    and replacing it with binding buffer in a ratio of 75% settled
    media to 25% buffer before packing. The binding buffer
    should not contain agents which significantly increase the
    viscosity. The column may be equilibrated with viscous
    buffers at reduced flow rates after packing is completed.2. Packing Sepharose 6B medium
    1. Equilibrate all material to the temperature at which the
    chromatography will be performed.
    2. De-gas the medium slurry.
    3. Eliminte air from the column dead spaces by flushing
    the end pieces with buffer. Make sure no air has been
    trapped under the column net. Close the column outlet
    with a few centimeters of buffer remaining in the
    column.
    4. Pour the slurry into the column in one continuous
    motion. Pouring the slurry down a glass rod held against
    the wall of the column will minimize the introduction of
    air bubbles.
    5. Immediately fill the remainder of the column with
    buffer, mount the column top piece onto the column and
    connect the column to a pump.
    6. Open the bottom outlet of the column and set the pump
    to run at the desired flow rate. This should be at least
    133% of the flow rate to be used during subsequent
    chromatographic procedures. However, the maximum
    flow rate, see Table 1, is typically employed during
    packing.
    Note: I f you have packed at the maximum linear flow
    rate, do not exceed 75% of this in subsequent
    chromatographic procedures.
    7. Maintain the packing flow rate for 3 bed volumes after a
    constant bed height is reached.
    For detailed desription on column packing, refer to our
    Handbook on Affinity Chromatography, Principles and
    Methods (18-1022-29), which can be downloaded from
    www.gehealthcare.com/protein-purification3.Using an adaptor
    Adaptors should be fitted as follows:
    1. After the medium has been packed as described above,
    close the column outlet and remove the top piece from
    the column. Carefully fill the rest of the column with
    buffer to form an upward meniscus at the top.
    2. Insert the adaptor at an angle into the column, ensuring
    that no air is trapped under the net.
    3. Make all tubing connections at this stage. There must be
    a bubble-free liquid connection between the column and
    the bump, and column and the sample application valve.
    4. Slide the plunger slowly down the column so that the air
    above the net and in the capillary tubings is displaced by
    eluent. Valves on the inlet side of the column should be
    turned in all directions during this procedure to ensure
    that air is removed.
    5. Lock the adaptor in position on the medium surface,
    open the column outlet and start the eluent flow. Pass
    eluent through the column at the packing flow rate until
    the medium bed is stable. Re-position the adaptor on the
    medium surface as necessary.
    The column is now equilibrated and ready for use.
    4. Binding of protein
    A suitable binding buffer is 50 mM Tris-HCl, pH 8.0 containing
    0.5 M NaCl. Good results are obtained at room temperature
    although the optimal temperature for binding is 4°C.
    After the sample has been loaded, wash the medium with
    binding buffer until the baseline is stable.5. Elution of protein
    Bound substances can be eluted specifically or nonspecifically.
    To elute bound substances specifically, a
    competing agent such as p-aminobenzamidine can be used.
    Competitive elution buffer:
    20 mM p-aminobenzamidine in binding buffer.
    Several methods may be used for non-specific elution of
    bound sucstances:
    &#8226; A change in ionic strenght alters the degree of ionization
    of the charged groups at the binding site. Elution is
    normally complete at salt concentrations of 1 M or less of
    NaCl. Either step or continuous gradients may be used.
    &#8226; A change in pH alters the degree of ionization of the
    charged groups at the binding. Either step or continuous
    gradients may be used.
    &#8226; Reduction of the polarity of the elution buffer byaddition
    of dioxane (up to 10%) or ethylene glycol (up to 50%)
    may be used for elution of bound substances.
    &#8226; Use of deforming agents like urea or guanidine
    hydrochloride is an alternative for elution of bound
    substances.
    6. Regeneration
    Depending of the nature of the sample, Benzamidine
    Sepharose 6B may be regenerated for re-use by washing
    the medium with 2–3 bed volumes of alternating high pH
    (0.1 M Tris-HCl + 0.5 M NaCl, pH 8.5) and low pH (0.1 M sodium
    acetate + 0.5 M NaCl, pH 4.5) buffers. This cycle should be
    repeated 3 times followed by re-equilibration with 3–5 bed
    volumes of binding buffer.
    If detergent or denaturing agents have been used during chromatography,
    these can also be used in the washing buffer.7. Cleaning
    In some applications, substances like denaturated proteins
    or lipids do not elute in the regeneration procedure. These
    can be removed by washing the column with a detergent
    solution, e.g. 0.1% Triton X-100 at 37°C for one minute.
    Re-equilibrate immediately with at least 5 bed volumes of
    binding buffer.
    8. Storage
    Benzamidine Sepharose 6B should be stored at 4–8°C in
    the presence of a suitable bacteriostatic agent, e.g. 20%
    ethanol, at neutral pH.
    9. Ordering Information
    Product Pack size Code No.
    Benzamidine Sepharose 6B 25 ml 17-0568-01
    10. References
    1. Purification and characterization of a trypsin-like serine
    proteinase from rat brain slices that degrades laminin
    and type IV collagen and stimulates protease-activated
    receptor-2. J. Neurochem. (2000), 74(4), 1731–1738,
    Sawada, K. et al.
    2. Purification of mast cell proteases from murine skin.
    Exp. Dermatol. (1999), 8(5), 413–418, Algermissen, B. et al.
    3. Purification of rabbit liver aldehyde oxidase by affinity
    chromatography on benzamidine Sepharose 6B.
    J. Chromatogr. (1989), 475 363-72, Stell, J. G. P. et al.
    4. The Crystal Structure of a T Cell Receptor in Complex
    with Peptide and MHC Class II. Science 1999 December 3;
    286: 1913–1921. Reinherz, Ellis L. et al.

    <li id="omoqo"></li>
  • <noscript id="omoqo"><kbd id="omoqo"></kbd></noscript>
  • <td id="omoqo"></td>
  • <option id="omoqo"><noscript id="omoqo"></noscript></option>
  • <noscript id="omoqo"><source id="omoqo"></source></noscript>
  • 1v3多肉多车高校生活的玩视频